NIP
AGN.PRA

Nicholas Investment Partners’s Allergan plc AGN.PRA Stock Holding History

Nicholas Investment Partners’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,040
Closed -$5.84M – 187
2017
Q2 		$6.09M Sell
7,040
-14,075
-67% -$11.8M 0.43% 53
2017
Q1 		$17.9M Sell
21,115
-60
-0.3% -$49.7K 1.26% 5
2016
Q4 		$16.1M Hold
21,175
– – 1.22% 3
2016
Q3 		$17.4M Hold
21,175
– – 1.16% 6
2016
Q2 		$17.7M Hold
21,175
– – 1.22% 5
2016
Q1 		$19.5M Sell
21,175
-530
-2% -$507K 1.42% 4
2015
Q4 		$22.3M Buy
21,705
+7,650
+54% +$7.68M 1.54% 3
2015
Q3 		$13.3M Sell
14,055
-1,165
-8% -$1.22M 0.95% 7
2015
Q2 		$15.9M Buy
+15,220
New +$15.9M 1.02% 9

Other funds holding AGN.PRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Nicholas Investment Partners's AGN.PRA Position: Q3 2017 in Review

Nicholas Investment Partners sold out of Allergan plc (AGN.PRA) in Q3 2017, closing a stake of 7,040 shares — an estimated $5.84M sold.

Nicholas Investment Partners first reported a position in AGN.PRA in Q2 2015 and held it in 9 quarters. The position peaked at $22.3M in Q4 2015. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2017.

  • Nicholas Investment Partners reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Nicholas Investment Partners sold 7,040 Allergan plc shares in Q3 2017, an estimated $5.84M.
  • Nicholas Investment Partners first reported a position in Allergan plc in Q2 2015 and held it in 9 quarters.
  • Nicholas Investment Partners's Allergan plc position peaked at $22.3M in Q4 2015.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Nicholas Investment Partners's 13F filing for Q3 2017, filed 13 Nov 2017.